Life Quality Determinant Assessment of Fibromyalgia Patients (FIBROQUALLIFE)
Life Quality Determinant Assessment of Fibromyalgia Patients Related to Health Devices
Sponsor: University Hospital, Strasbourg, France
Terminated
recruitment difficulty
Other terminated trials from University Hospital, Strasbourg, France
- Healthy Control Subjects · Apr 2025
- Cystic Fibrosis-related Diabetes · Phase PHASE4 · Jan 2025
- Kidney Transplant Recipients · Nov 2024
- Diagnosed With Uretral Fibroscopy · Sep 2024
- Patients with Colorectal Cancer · Phase NA · Sep 2024
See all terminations from University Hospital, Strasbourg, France
Other Fibromyalgia trials with similar outcome
A NA clinical study on Fibromyalgia, this trial is terminated or withdrawn. The trial is conducted by University Hospital, Strasbourg, France and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Oct 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2019 — Aug 2020 [monthly]
Recruiting NA
-
Sep 2018 — Sep 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jul 2017 — Oct 2017 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — Jul 2017 [monthly]
Not Yet Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Strasbourg, France
For direct contact, visit the study record on ClinicalTrials.gov .